Kalypsys

About:

Kalypsys provides drug discovery and development services.

Top Investors: 5AM Ventures, Novartis Venture Fund, Tavistock Life Sciences, CMEA Capital, CMEA Ventures

Description:

Kalypsys provides pathway-based drug discovery and development services. The company implements discovery programs across a broad number of therapeutic areas using its automated and integrated suite of discovery technologies in biology, chemistry and informatics.

Total Funding Amount:

$171M

Headquarters Location:

San Diego, California, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)kalypsys.com

Founders:

Kevin Lustig, Peter Schultz, Pratik Shah, Randall King

Number of Employees:

101-250

Last Funding Date:

2006-11-29

IPO Status:

Private

Industries: